D2C Life Science is a specialized consultancy focused on pharmaceutical GMP quality management, offering auditing, consulting, training, and project management services. The company targets pharmaceutical manufacturers, contract manufacturers, and hospitals implementing GMP for advanced therapies. Their website demonstrates a modern technical infrastructure using the Astro framework, with excellent design, mobile optimization, and clear content structure. Security posture is moderate with no detected security headers or incident response information, and the WHOIS data is missing, which raises some trust concerns. Privacy compliance is strong with a comprehensive privacy policy, but cookie consent mechanisms are absent. Overall, the website is professional and trustworthy, but improvements in security transparency and domain registration clarity are recommended.
Scanned ·
NIS2 and GDPR posture
GDPR outside view
35/ 100 · High
Checks completed
7of 7
NIS2 Art. 21(2)
a(a) Risk analysis and security policies: Not visible from outside
b(b) Incident handling: One indicator
c(c) Business continuity, backups and crisis management: Not visible from outside
d(d) Supply chain security: Not visible from outside
e(e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
f(f) Assessing the effectiveness of security measures: Not visible from outside
g(g) Cyber hygiene and security training: Not visible from outside
h(h) Cryptography and encryption: Partly checked
i(i) HR security, access control and asset management: One indicator
j(j) Multi-factor authentication and secured communications: Not visible from outside
Partly checked
One indicator
Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
7 findings rated critical or high. Fix these first.
Security headers
Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.
High
Missing X-Frame-Options header
Prevents clickjacking attacks
What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"
This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended
€25per month
TLS certificates and expiry
DNS records
SPF, DKIM and DMARC
Security headers
GDPR and NIS2 posture
Exposed services
Third-party trackers
Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.
Full report
€39.90one-time
The complete analysis as a PDF you can cite
Email delivery with an unlock code
Lifetime access to this report
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
SSL/TLS
75
Security headers
30
Email security
70
DNS health
75
Network security
100
GDPR outside view
35
Average
64
Not counted
NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
The certificate is not trusted by browsers
The website is not served over HTTPS
A database, remote desktop, file-sharing or Telnet service is reachable from the internet
The page loads a script from a compromised source
The domain registration has expired
SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Critical0–25
High26–49
Medium50–75
Low76–100
Breach exposure
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Dark web exposure
Add-on
Leaked records that mention d2c-lifescience.com, from OffSeq Breach.
No leaked records found
Breach holds no records for d2c-lifescience.com right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
The company operates in the healthcare sector, focusing on GMP consulting and quality management. Their business model revolves around providing expert services to pharmaceutical and life sciences organizations, emphasizing data-driven decision making and operational excellence. The firm is small-sized, founded in 2021, and based in France. They maintain a professional online presence with LinkedIn profiles for key founders. The absence of WHOIS data is a notable anomaly. The company positions itself as a niche expert with a strong focus on quality culture and risk management, targeting a specialized market segment with high regulatory demands.
Security posture
The website uses HTTPS but lacks visible security headers and explicit security policies. No incident response or vulnerability disclosure information is provided. No security-related scripts or analytics that could pose privacy risks were detected. The privacy policy is comprehensive and GDPR compliant, indicating good data protection awareness. The missing WHOIS data and lack of cookie consent mechanism are weaknesses. Overall, the security posture is moderate but could be improved by adding security headers, incident response contacts, and cookie consent.
Recommendations
Implement standard security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
Add a cookie consent banner to comply with privacy regulations and improve user trust.
Publish a clear security policy and incident response contact information on the website.
Investigate and resolve the missing WHOIS registration data to improve domain trustworthiness.
Consider adding a vulnerability disclosure policy or security.txt file to enhance transparency.
Automated reading of the public site. Ratings are indicative.
Business
Company
D2C Life Science
Description
D2C Life Science empowers organizations in the pharmaceutical and life sciences sector to move beyond compliance by leveraging data-driven insights and hands-on leadership to optimize GMP quality management and operational excellence.
Key services
Audit, Consulting, Training, Project Management
Content quality
excellent
Branding
consistent
Technology
Stack
Astro framework, JavaScript, SVG graphics
Frameworks
Astro
Performance
fast
Mobile
excellent
Accessibility
good
SEO
good
Security
Observed score
70/100
Good practices seen
No exposed sensitive data in HTML
No inline scripts with suspicious content
Analytics and tracking
Tracking level
minimal
Privacy practices
good
Advertising
Transparency
poor
Site quality
Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high
Key observations
Website is fully accessible with rich content and professional design
No WAF or blocking mechanisms detected
WHOIS data missing or domain unregistered per raw WHOIS output
Privacy policy is comprehensive and GDPR compliant
No cookie consent mechanism detected
Contact information is clearly provided with email, phone, and physical address
No explicit security policies or incident response contacts found
No advertising or tracking scripts detected
No analytics services detected
Content is safe and suitable for general audiences
Technical notes
Notes
The website is built using the Astro framework, leveraging modern JavaScript and SVG graphics for a visually appealing and performant experience. The site is mobile-optimized and accessible, with good SEO metadata and Open Graph tags. No CMS or third-party analytics/tracking services were detected, indicating a lightweight and privacy-conscious implementation. Hosting provider details are not available. The site loads quickly and has a clean, professional design. Technical debt appears low, but security header implementation and cookie consent are areas for improvement.
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Reviews of this site
Share your experience with d2c-lifescience.com. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review d2c-lifescience.com.